Tweenvest Stocks

Diagnamed Holdings Corp. (CNSX: DMED)

Health Care · Health Care Technology · CA

CA$0.04

-11.11% today · -60.0% 1Y

Diagnamed Holdings Corp. (CNSX: DMED) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $3.69M and employs 5 people.

Over the last twelve months the share price has lost 60.0%, trading between 0.03 and 0.25.

Tweenvest scores Diagnamed Holdings Corp. across four factors: quality 21/100, value 53/100. Its strongest factor is value.

DMED price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$3.69M
Revenue (TTM)
—
P/E
—
EPS
-0.02
Dividend yield
—
Beta (5Y)
-1.05
52-week high
CA$0.25
52-week low
CA$0.03
Avg volume (3M)
—
Shares outstanding
131.61M
Employees
5
Next earnings
—

About Diagnamed Holdings Corp.

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.

ISIN
CA25245D1033
Listed since
Nov 8, 2022
Exchange
Canadian National Stock Exchange
Currency
CAD
CompanyMarket capPriceDay
Apptly Health Technologies Corp.CNSX: APPT$4.55MCA$0.11-4.55%
Kontigo Care AB (publ)XSAT: KONT$4.47MSkr1.27-7.51%
Aino Health AB (publ)OM: AINO$4.13MSkr0.21+3.96%
HITIQ LimitedASX: HIQ$4.04MAU$0.01-16.67%
Feedback plcAIM: FDBK$3.68M£0.07+5.51%
Monsenso A/SCPSE: MONSO$3.59MDkr0.24-4.00%
StrainsforPains, Inc.OTCPK: EBYH$2.99M$0.23+15.57%
Adherium LimitedASX: ADR$2.95MAU$0.08+2.67%

Browse every Health Care Technology company →

Figures last refreshed Oct 11, 2026.